# A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines

> clinical trial · VERIFIED · 2026-06-26

Status: COMPLETED · Sponsor: AbbVie · Condition: Glabellar Lines

- Company: AbbVie
- Sector: aesthetics
- Primary source: https://clinicaltrials.gov/study/NCT05496335

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.